Clinical Assistant Professor, Department of Pediatric and Adolescent Medicine
Biosketch
Peter Schoettler, MD, is a board-certified pediatrician (and board-eligible pediatric hematologist/oncologist) with Bronson Children's Hospital in Kalamazoo, Michigan. He is a graduate of the University of Minnesota Medical School. He completed his residency in pediatrics at the University of California-Irvine/Children's Hospital of Orange County. He then completed a pediatric hematology/oncology fellowship at the University of Texas Southwestern Medical Center. His clinical and research interests include DICER1 Syndrome.
-
Education and Training
- Clinical Fellowship 2021, Pediatric Hematology and Oncology, University of Texas Southwestern Medical Center at Dallas
- Residency 2018, Pediatrics, University of California-Irvine
- MD 2015, University of Minnesota
- BS 2011, Chemistry, University of Minnesota
-
Research
- DICER1 Syndrome
-
Publications
Martin C.E., Kuhn A.K., Leopold K.N., Creo A.L., Schoettler P.J., Allen-Rhoades W.A. Exogenous steroid replacement in a pediatric patient with adrenocortical carcinoma receiving mitotane Pediatric Blood and Cancer. 2024;71
Schoettler P.J., Smith C.C., Nishitani M., Harris A.K., Nelson A.T., Watson D.A., Kamihara J., Mullen E.A., Hill D.A., Messinger Y.H., Fair D.B., Kumar K.A., Dehner L.P., Ash S., Chen K.S., Schultz K.A.P. Anaplastic sarcoma of the kidney (DICER1-sarcoma of the kidney): A report from the International Pleuropulmonary Blastoma/DICER1 Registry Pediatric Blood and Cancer. 2024;71
Schultz K.A.P., Nelson A.T., Mallinger P.H.R., Harris A.K., Kamihara J., Baldinger S., Chen K.S., Pond D., Hatton J.N., Dybvik A.G., Mitchell S.G., Perrino M.R., Ben-Ami T., Kachanov D., Su Y., Duan C., Olson D.R., Watson D., Field A.L., Harney L.A., Carr A.G., Frazier A.L., Schneider D.T., Wilson D.B., MacFarland S.P., Schoettler P.J., Bauer A.J., Dehner L.P., Hill D.A., Stewart D.R., Messinger Y.H. DICER1-Related Tumor Predisposition: Identification of At-risk Individuals and Recommended Surveillance Strategies Clinical Cancer Research. 2024;30:5681-5692.
Hill D.A., Brenneman M., Field A., Yang J., Williams G., Doros L., Rossi C., Schultz K.A., Rosenberg A., Ivanovich J., Turner J., Gordish-Dressman H., Stewart D., Yu W., Harris A., Schoettler P., Goodfellow P., Dehner L., Messinger Y. Temporal order of RNase IIIb and loss-of-function mutations during development determines phenotype in pleuropulmonary blastoma / DICER1 syndrome: A unique variant of the two-hit tumor suppression model F1000Research. 2018;4
Nossair F., Schoettler P., Starr J., Chan A.K.C., Kirov I., Paes B., Mahajerin A. Pediatric superior vena cava syndrome: An evidence-based systematic review of the literature Pediatric Blood and Cancer. 2018;65(9)
Hill D.A., Jarzembowski J.A., Priest J.R., Williams G., Schoettler P., Dehner L.P. Type I pleuropulmonary blastoma: Pathology and biology study of 51 cases from the International Pleuropulmonary Blastoma Registry American Journal of Surgical Pathology. 2008;32(2):282-295.